Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'MDM2' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 813 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Atencio, IA; Avanzini, JB; Johnson, D; Neuteboom, S; Vaillancourt, MT; Nielsen, LL; Hajian, G; Sutjipto, S; Sugarman, BJ; Philopena, J; McAllister, DL; Beltran, JC; Nodelman, M; Ramachandra, M; Wills, KN
      Enhanced apoptotic activity of a p53 variant in tumors resistant to wild-type p53 treatment

      MOLECULAR THERAPY
    2. Dornan, D; Hupp, TR
      Inhibition of p53-dependent transcription by BOX-I phospho-peptide mimetics that bind to p300

      EMBO REPORTS
    3. Millon, R; Muller, D; Schultz, I; Salvi, R; Ghnassia, JP; Frebourg, T; Wasylyk, B; Abecassis, J
      Loss of MDM2 expression in human head and neck squamous cell carcinomas and clinical significance

      ORAL ONCOLOGY
    4. Lopes, MA; Nikitakis, NG; Ord, RA; Sauk, J
      Amplification and protein expression of chromosome 12q13-15 genes in osteosarcomas of the jaws

      ORAL ONCOLOGY
    5. Viswanathan, M; Tsuchida, N; Shanmugam, G
      Selective deletion of p14(ARF) exon 1 beta of the INK4a locus in oral squamous cell carcinomas of Indians

      ORAL ONCOLOGY
    6. Chene, P
      p53 as a drug target in cancer therapy

      EXPERT OPINION ON THERAPEUTIC PATENTS
    7. Zhao, X; Demary, K; Wong, L; Vaziri, C; McKenzie, AB; Eberlein, TJ; Spanjaard, RA
      Retinoic acid receptor-independent mechanism of apoptosis of melanoma cells by the retinoid CD437 (AHPN)

      CELL DEATH AND DIFFERENTIATION
    8. Horie, S; Maeta, H; Endo, K; Ueta, T; Takashima, K; Terada, T
      Overexpression of p53 protein and MDM2 in papillary carcinomas of the thyroid: Correlations with clinicopathologic features

      PATHOLOGY INTERNATIONAL
    9. Jabbur, JR; Huang, P; Zhang, W
      Enhancement of the antiproliferative function of p53 by phosphorylation atserine 20: An inference from site-directed mutagenesis studies

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    10. Puigserver, P; Rhee, J; Lin, JD; Wu, ZD; Yoon, JC; Zhang, CY; Krauss, S; Mootha, VK; Lowell, BB; Spiegelman, BM
      Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPAR gamma coactivator-1

      MOLECULAR CELL
    11. Demonacos, C; Krstic-Demonacos, M; La Thangue, NB
      A TPR motif cofactor contributes to p300 activity in the p53 response

      MOLECULAR CELL
    12. Nikitakis, NG; Lopes, MA; Pazoki, AE; Ord, RA; Sauk, JJ
      MDM2+/CDK4+/p53+oral liposarcoma: Case report and review of the literature

      ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS
    13. Maas, RM; Reus, K; Diesel, B; Steudel, WI; Feiden, W; Fischer, U; Meese, E
      Amplification and expression of splice variants of the gene encoding the P450 cytochrome 25-hydroxyvitamin D-3 1,alpha-hydroxylase (CYP 27B1) in human malignant glioma

      CLINICAL CANCER RESEARCH
    14. Wang, H; Nan, L; Yu, D; Agrawal, S; Zhang, RW
      Antisense anti-MDM2 oligonucleotides as a novel therapeutic approach to human breast cancer: In vitro and in vivo activities and mechanisms

      CLINICAL CANCER RESEARCH
    15. Reles, A; Wen, WH; Schmider, A; Gee, C; Runnebaum, IB; Kilian, U; Jones, LA; El-Naggar, A; Minguillon, C; Schonborn, I; Reich, O; Kreienberg, R; Lichtenegger, W; Press, MF
      Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer

      CLINICAL CANCER RESEARCH
    16. Lutzker, SG; Lattime, EC
      Use of dendritic cells to immunize against cancers overexpressing p53

      CLINICAL CANCER RESEARCH
    17. Gump, J; McGavran, L; Wei, Q; Hunger, SP
      Analysis of TP53 mutations in relapsed childhood acute lymphoblastic leukemia

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    18. Adachi, T; Oda, Y; Sakamoto, A; Saito, T; Tamiya, S; Masuda, I; Tsuneyoshi, M
      Immunoreactivity of p53, mdm2, and p21(WAF1) in dedifferentiated liposarcoma: Special emphasis on the distinct immunophenotype of the well-differentiated component

      INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY
    19. Parant, J; Chavez-Reyes, A; Little, NA; Yan, W; Reinke, V; Jochemsen, AG; Lozano, G
      Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53

      NATURE GENETICS
    20. Xu, XL; Qiao, WH; Linke, SP; Cao, L; Li, WM; Furth, PA; Harris, CC; Deng, CX
      Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis,cell cycle and tumorigenesis

      NATURE GENETICS
    21. O'Connor, DP; Kay, EW; Leader, M; Murphy, GM; Atkins, GJ; Mabruk, MJEMF
      Altered p53 expression in benign and malignant skin lesions from renal transplant recipients and immunocompetent patients with skin cancer: Correlation with human papillomaviruses?

      DIAGNOSTIC MOLECULAR PATHOLOGY
    22. Shi, Y; Zou, M; Varkondi, E; Nagy, A; Kozma, L; Farid, NR
      Cyclin D1 in thyroid carcinomas

      THYROID
    23. Carstens, BP; Perry, ME
      Purification of a fragment of MDM2 for production of polyclonal antisera

      PROTEIN EXPRESSION AND PURIFICATION
    24. Dominguez, C; Silva, J; Silva, JM; Garcia, JM; Larrondo, FJ; Vargas, J; Sanfrutos, L; Provencio, M; Espana, P; Bonilla, F
      Different expression of P14ARF defines two groups of breast carcinomas in terms of TP73 expression and TP53 mutational status

      GENES CHROMOSOMES & CANCER
    25. Fang, Y; Guan, XY; Guo, Y; Sham, JST; Deng, MQ; Liang, QW; Li, HM; Zhang, HG; Zhou, H; Trent, J
      Analysis of genetic alterations in primary nasopharyngeal carcinoma by comparative genomic hybridization

      GENES CHROMOSOMES & CANCER
    26. Zhang, YP; Xiong, Y
      Control of p53 ubiquitination and nuclear export by MDM2 and ARF

      CELL GROWTH & DIFFERENTIATION
    27. Park, YK; Chi, SG; Kim, YW; Park, HR; Unni, KK
      P53 mutations in Ewing's sarcoma

      ONCOLOGY REPORTS
    28. Guerra, B; Boldyreff, B; Issinger, OG
      FAS-associated factor 1 interacts with protein kinase CK2 in vivo upon apoptosis induction

      INTERNATIONAL JOURNAL OF ONCOLOGY
    29. Zhang, H; Rosdahl, I
      Expression of oneogenes, tumour suppressor, mismatch repair and apoptosis-related genes in primary and metastatic melanoma cells

      INTERNATIONAL JOURNAL OF ONCOLOGY
    30. Evdokiou, A; Atkins, GJ; Bouralexis, S; Hay, S; Raggatt, LJ; Cowled, PA; Graves, SE; Clayer, M; Findlay, DM
      Expression of alternatively-spliced MDM2 transcripts in giant cell tumoursof bone

      INTERNATIONAL JOURNAL OF ONCOLOGY
    31. Ginath, S; Menczer, J; Friedmann, Y; Aingorn, H; Aviv, A; Tajima, K; Dantes, A; Glezerman, M; Vlodavsky, I; Amsterdam, A
      Expression of heparanase, Mdm2, and erbB2 in ovarian cancer

      INTERNATIONAL JOURNAL OF ONCOLOGY
    32. Yoshida, Y; Hosokawa, K; Dantes, A; Kotsuji, F; Kleinman, HK; Amsterdam, A
      Role of laminin in ovarian cancer turner growth and metastasis via regulation of Mdm2 and Bcl-2 expression

      INTERNATIONAL JOURNAL OF ONCOLOGY
    33. Brown, DR; Deb, D; Frum, R; Hickes, L; Munoz, R; Deb, S; Deb, SP
      The human oncoprotein MDM2 uses distinct strategies to inhibit transcriptional activation mediated by the wild-type p53 and its tumor-derived mutants

      INTERNATIONAL JOURNAL OF ONCOLOGY
    34. Technau, A; Wolff, A; Sauder, C; Birkner, N; Brandner, G
      p53 in SV40-transformed DNA-damaged human cells binds to its cognate sequence but fails to transactivate target genes

      INTERNATIONAL JOURNAL OF ONCOLOGY
    35. Mitlianga, PG; Kyritsis, AP; Gomez-Manzano, C; Lemoine, MG; Hu, M; Liu, TJ; Yung, WKA; Fueyo, J
      Co-expression of E2F-2 enhances the p53 anti-cancer effect in human gliomacells

      INTERNATIONAL JOURNAL OF ONCOLOGY
    36. Scheil, S; Bruderlein, S; Eicker, M; Herms, J; Herold-Mende, C; Steiner, HH; Barth, TFE; Moller, P
      Low frequency of chromosomal imbalances in anaplastic ependymomas as detected by comparative genomic hybridization

      BRAIN PATHOLOGY
    37. Nevins, JR
      The Rb/E2F pathway and cancer

      HUMAN MOLECULAR GENETICS
    38. Randerson-Moor, JA; Harland, M; Williams, S; Cuthbert-Heavens, D; Sheridan, E; Aveyard, J; Sibley, K; Whitaker, L; Knowles, M; Bishop, JN; Bishop, DT
      A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural systemtumour syndrome family

      HUMAN MOLECULAR GENETICS
    39. Ohnuma, S; Philpott, A; Harris, WA
      Cell cycle and cell fate in the nervous system

      CURRENT OPINION IN NEUROBIOLOGY
    40. Eymin, B; Karayan, L; Seite, P; Brambilla, C; Brambilla, E; Larsen, CJ; Gazzeri, S
      Human ARF binds E2F1 and inhibits its transcriptional activity

      ONCOGENE
    41. Karayan, L; Riou, JF; Seite, P; Migeon, J; Cantereau, A; Larsen, CJ
      Human ARF protein interacts with Topoisomerase I and stimulates its activity

      ONCOGENE
    42. Latonen, L; Taya, Y; Laiho, M
      UV-radiation induces dose-dependent regulation of p53 response and modulates p53-HDM2 interaction in human fibroblasts

      ONCOGENE
    43. Waddell, S; Jenkins, JR; Proikas-Cezanne, T
      A 'no-hybrids' screen for functional antagonizers of human p53 transactivator function: dominant negativity in fission yeast

      ONCOGENE
    44. Michalowski, J; Seavey, SE; Mendrysa, SM; Perry, ME
      Defects in transcription coupled repair interfere with expression of p90(MDM2) in response to ultraviolet light

      ONCOGENE
    45. Rizos, H; Puig, S; Badenas, C; Malvehy, J; Darmanian, AP; Jimenez, L; Mila, M; Kefford, RF
      A melanoma-associated germline mutation in exon 1 beta inactivates p14ARF

      ONCOGENE
    46. Kim, H; You, S; Linda, KF; Farris, J; Foster, DN
      The rapid destabilization of p53 mRNA in immortal chicken embryo fibroblast cells

      ONCOGENE
    47. Lomax, M; Fried, M
      Polyoma virus disrupts ARF signaling to p53

      ONCOGENE
    48. Xirodimas, D; Saville, MK; Edling, C; Lane, DP; Lain, S
      Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 invivo

      ONCOGENE
    49. Little, NA; Jochemsen, AG
      Hdmx and Mdm2 can repress transcription activation by p53 but not by p63

      ONCOGENE
    50. Evans, SC; Viswanathan, M; Grier, JD; Narayana, M; El-Naggar, AK; Lozano, G
      An alternatively spliced HDM2 product increases p53 activity by inhibitingHDM2

      ONCOGENE
    51. Bensaad, K; Rouillard, D; Soussi, T
      Regulation of the cell cycle by p53 after DNA damage in an amphibian cell line

      ONCOGENE
    52. Gu, JJ; Rubin, RM; Yuan, ZM
      A sequence element of p53 that determines its susceptibility to viral oncoprotein-targeted degradation

      ONCOGENE
    53. Minamoto, T; Buschmann, T; Habelhah, H; Matusevich, E; Tahara, H; Boerresen-Dale, AL; Harris, C; Sidransky, D; Ronai, Z
      Distinct pattern of p53 phosphorylation in human tumors

      ONCOGENE
    54. Lu, WG; Chen, LH; Peng, YH; Chen, JD
      Activation of p53 by roscovitine-mediated suppression of MDM2 expression

      ONCOGENE
    55. Kim, H; You, S; Farris, J; Foster, LK; Foster, DN
      Post-transcriptional inactivation of p53 in immortalized murine embryo fibroblast cells

      ONCOGENE
    56. Frost, V; Al-Mehairi, S; Sinclair, AJ
      Exploitation of a non-apoptotic caspase to regulate the abundance of the cdkI p27(KIP1) in transformed lymphoid cells

      ONCOGENE
    57. Kwek, SSS; Derry, J; Tyner, AL; Shen, ZY; Gudkov, AV
      Functional analysis and intracellular localization of p53 modified by SUMO-1

      ONCOGENE
    58. Lindstrom, MS; Klangby, U; Wiman, KG
      p14ARF homozygous deletion or MDM2 overexpression in Burkitt lymphoma lines carrying wild type p53

      ONCOGENE
    59. Argentini, M; Barboule, N; Wasylyk, B
      The contribution of the acidic domain of MDM2 to p53 and MDM2 stability

      ONCOGENE
    60. Wolff, A; Technau, A; Ihling, C; Technau-Ihling, K; Erber, R; Bosch, FX; Brandner, G
      Evidence that wild-type p53 in neuroblastoma cells is in a conformation refractory to integration into the transcriptional complex

      ONCOGENE
    61. Stewart, ZA; Tang, LJ; Pietenpol, JA
      Increased p53 phosphorylation after microtubule disruption is mediated in a microtubule inhibitor- and cell-specific manner

      ONCOGENE
    62. Mayr, B; Gruneis, C; Brem, G; Reifinger, M; Schaffner, G; Hochsteiner, W
      Lack of sequence variation in sporadic bovine leucosis in regions of tumour suppressor genes p53 and p16

      JOURNAL OF VETERINARY MEDICINE SERIES A-PHYSIOLOGY PATHOLOGY CLINICAL MEDICINE
    63. Yang, HL; Dong, YB; Elliott, MJ; Wong, SL; McMasters, KM
      Additive effect of adenovirus-mediated E2F-1 gene transfer and topoisomerase II inhibitors on apoptosis in human osteosarcoma cells

      CANCER GENE THERAPY
    64. Daujat, S; Neel, H; Piette, J
      Preferential expression of Mdm2 oncogene during the development of neural crest and its derivatives in mouse early embryogenesis

      MECHANISMS OF DEVELOPMENT
    65. Huang, JS; Ho, TJ; Chiang, CP; Kok, SH; Kuo, YS; Kuo, MYP
      MDMP expression in areca quid chewing-associated oral squamous cell carcinomas in Taiwan

      JOURNAL OF ORAL PATHOLOGY & MEDICINE
    66. Fischer, U; Hemmer, D; Heckel, D; Michel, A; Feiden, W; Steudel, WI; Hulsebos, T; Meese, E
      KUB3 amplification and overexpression in human gliomas

      GLIA
    67. Leite, KRM; Franco, MF; Srougi, M; Nesrallah, LJ; Nesrallah, A; Bevilacqua, RG; Darini, E; Carvalho, CM; Meirelles, MI; Santana, I; Camara-Lopes, LH
      Abnormal expression of MDM2 in prostate carcinoma

      MODERN PATHOLOGY
    68. Bai, M; Vlachonikolis, J; Agnantis, NJ; Tsanou, E; Dimou, S; Nicolaides, C; Stefanaki, S; Pavlidis, N; Kanavarous, P
      Low expression of p27 protein combined with altered p53 and Rb/p16 expression status is associated with increased expression of cyclin A and cyclin B1 in diffuse large B-cell lymphomas

      MODERN PATHOLOGY
    69. Geradts, J; Wilentz, RE; Roberts, H
      Utimmunohistochemical detection of the alternate INK4a-encoded tumor suppressor protein p14(ARF) in archival human cancers and cell lines using commercial antibodies: Correlation with p16(INK4a) expression

      MODERN PATHOLOGY
    70. Maya, R; Balass, M; Kim, ST; Shkedy, D; Leal, JFM; Shifman, O; Moas, M; Buschmann, T; Ronai, Z; Shiloh, Y; Kastan, MB; Katzir, E; Oren, M
      ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage

      GENES & DEVELOPMENT
    71. Inoue, K; Zindy, F; Randle, DH; Rehg, JE; Sherr, CJ
      Dmp1 is haplo-insufficient for tumor suppression and modifies the frequencies of Arf and p53 mutations in Myc-induced lymphomas

      GENES & DEVELOPMENT
    72. Galatin, PS; Abraham, DJ
      QSAR: Hydropathic analysis of inhibitors of the p53-mdm2 interaction

      PROTEINS-STRUCTURE FUNCTION AND GENETICS
    73. Majeux, N; Scarsi, M; Caflisch, A
      Efficient electrostatic solvation model for protein-fragment docking

      PROTEINS-STRUCTURE FUNCTION AND GENETICS
    74. Esteller, M; Gonzalez, S; Risques, RA; Marcuello, E; Mangues, R; Germa, JR; Herman, JG; Capella, G; Peinado, MA
      K-ras and p16 aberrations confer poor prognosis in human colorectal cancer

      JOURNAL OF CLINICAL ONCOLOGY
    75. Mendrysa, SM; McElwee, MK; Perry, ME
      Characterization of the 5 ' and 3 ' untranslated regions in murine mdm2 mRNAs

      GENE
    76. Pagnano, KBB; Vassallo, J; Lorand-Metze, I; Costa, FF; Saad, STO
      p53, Mdm2, and c-Myc overexpression is associated with a poor prognosis inaggressive non-Hodgkin's lymphomas

      AMERICAN JOURNAL OF HEMATOLOGY
    77. Boltze, C; Schneider-Stock, R; Jager, V; Roessner, A
      Distinction between lipoma and liposarcoma by MDM2 alterations: A case report of simultaneously occurring tumors and review of the literature

      PATHOLOGY RESEARCH AND PRACTICE
    78. Watanabe, T; Oda, Y; Tamiya, S; Kinukawa, N; Masuda, K; Tsuneyoshi, M
      Malignant peripheral nerve sheath tumours: high Ki67 labelling index is the significant prognostic indicator

      HISTOPATHOLOGY
    79. Hakin-Smith, V; Battersby, RD; Maltby, EL; Timperley, WR; Royds, JA
      Elevated p53 expression in benign meningiomas protects against recurrence and may be indicative of senescence

      NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
    80. Nasir, L; Rutteman, GR; Reid, SWJ; Schulze, C; Argyle, DJ
      Analysis of p53 mutational events and MM2 amplification in canine soft-tissue sarcomas

      CANCER LETTERS
    81. Cheung, TH; Lo, KWK; Yu, MMY; Yim, SF; Poon, CS; Chung, TKH; Wong, YF
      Aberrant expression of p21(WAF1/CIP1) and p27(KIP1) in cervical carcinoma

      CANCER LETTERS
    82. Schumacher, U; Adam, E; Feldhaus, S; Katoh, M; Lane, DP
      Cell differentiation and chemotherapy influence p53 and Mdm2 immunoreactivity in human HT29 colon cancer cells grown in scid mice

      CANCER LETTERS
    83. Miyajima, K; Tamiya, S; Oda, Y; Adachi, T; Konomoto, T; Toyoshiba, H; Masuda, K; Tsuneyoshi, M
      Relative quantitation of p53 and MDM2 gene expression in leiomyosarcoma; real-time semi-quantitative reverse transcription-polymerase chain reaction

      CANCER LETTERS
    84. Lohrum, MAE; Woods, DB; Ludwig, RL; Balint, E; Vousden, KH
      C-terminal ubiquitination of p53 contributes to nuclear export

      MOLECULAR AND CELLULAR BIOLOGY
    85. Gu, JJ; Nie, LH; Wiederschain, D; Yuan, ZM
      Identification of p53 sequence elements that are required for MDM2-mediated nuclear export

      MOLECULAR AND CELLULAR BIOLOGY
    86. Sionov, RV; Coen, S; Goldberg, Z; Berger, M; Bercovich, B; Ben-Neriah, Y; Ciechanover, A; Haupt, Y
      c-Abl regulates p53 levels under normal and stress conditions by preventing its nuclear export and ubiquitination

      MOLECULAR AND CELLULAR BIOLOGY
    87. Bai, LG; Merchant, JL
      ZBP-89 promotes growth arrest through stabilization of p53

      MOLECULAR AND CELLULAR BIOLOGY
    88. Zilfou, JT; Hoffman, WH; Sank, M; George, DL; Murphy, M
      The corepressor mSin3a interacts with the proline-rich domain of p53 and protects p53 from proteasome-mediated degradation

      MOLECULAR AND CELLULAR BIOLOGY
    89. Szak, ST; Mays, D; Pietenpol, JA
      Kinetics of p53 binding to promoter sites in vivo

      MOLECULAR AND CELLULAR BIOLOGY
    90. Dumaz, N; Milne, DM; Jardine, LJ; Meek, DW
      Critical roles for the serine 20, but not the serine 15, phosphorylation site and for the polyproline domain in regulating p53 turnover

      BIOCHEMICAL JOURNAL
    91. Hjerrild, M; Milne, D; Dumaz, N; Hay, T; Issinger, OG; Meek, D
      Phosphorylation of murine double minute clone 2 (MDM2) protein at serine-267 by protein kinase CK2 in vitro and in cultured cells

      BIOCHEMICAL JOURNAL
    92. Sugita, K; Chi, XJ; Hiwasa, T; Suzuki, N
      Studies on p53 and Bax protein expression in Cockayne syndrome cells afterUV irradiation and interferon-beta treatment

      CELL BIOCHEMISTRY AND FUNCTION
    93. Bech-Otschir, D; Kraft, R; Huang, XH; Henklein, P; Kapelari, B; Pollmann, C; Dubiel, W
      COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system

      EMBO JOURNAL
    94. Ito, A; Lai, CH; Zhao, X; Saito, S; Hamilton, MH; Appella, E; Yao, TP
      p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2

      EMBO JOURNAL
    95. Grunbaum, U; Meye, A; Bache, M; Bartel, F; Wurl, P; Schmidt, H; Dunst, J; Taubert, H
      Transfection with mdm2-antisense or wtp53 results in radio sensitization and an increased apoptosis of a soft tissue sarcoma cell line

      ANTICANCER RESEARCH
    96. Kinoshita, Y; Shiratsuchi, H; Tamiya, S; Oshiro, Y; Hachitanda, Y; Oda, Y; Suita, S; Tsuneyoshi, M
      Mutations of the p53 gene in malignant rhabdoid tumors of soft tissue and the kidney: immunohistochemical and DNA direct sequencing analysis

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    97. Tan, ZQ; Tu, WL; Schreiber, SS
      Downregulation of free ubiquitin: a novel mechanism of p53 stabilization and neuronal cell death

      MOLECULAR BRAIN RESEARCH
    98. Daujat, S; Neel, H; Piette, J
      MDM2: life without p53

      TRENDS IN GENETICS
    99. Ho, GH; Calvano, JE; Bisogna, M; Abouezzi, Z; Borgen, PI; Cordon-Cardo, C; Van Zee, KJ
      Genetic alterations of the p14(ARF)-hdm2-p53 regulatory pathway in breast carcinoma

      BREAST CANCER RESEARCH AND TREATMENT
    100. Forus, A; Bjerkehagen, B; Sirvent, N; Meza-Zepeda, LA; Coindre, JM; Berner, JM; Myklebost, O; Pedeutourd, F
      A well-differentiated liposarcoma with a new type of chromosome 12-derivedmarkers

      CANCER GENETICS AND CYTOGENETICS


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/05/20 alle ore 23:32:42